Enhanc3D Genomics expands leadership team with the appointment of Hazel Jones as Chief Operating Officer Post author: Post published:November 6, 2023 Post category:uncategorized Enhanc3D Genomics today announced the appointment of Hazel Jones as Chief Operating Officer. You Might Also Like Lifestyle interventions in patients after colorectal cancer treatment September 4, 2024 Study offers insights into who’s at risk for long COVID among immunocompromised patients January 27, 2024 Proteogenomics reveals new target for beating drug resistance in acute myeloid leukemia February 2, 2024
Study offers insights into who’s at risk for long COVID among immunocompromised patients January 27, 2024
Proteogenomics reveals new target for beating drug resistance in acute myeloid leukemia February 2, 2024